Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Hepatology. 2012 Oct;56(4):1223–1230. doi: 10.1002/hep.25755

Table 4.

The Relation of Pretreatment Alcohol Intake to HCV Treatment Failure, Adjusted for Host and Viral Risk Factors. Multiple Logistic Regression, Adjusted Odds Ratios, 95% Confidence Intervals (CI), and Significance Levels (N = 181)

Risk Factors Odds Ratios (95% CI) ρ Values
Hispanic and/or non-White 2.99 (1.23 – 7.22) .016
Pretreatment Viral Load 2.11 (1.03 – 4.33) .042
HCV Genotype 1/4/6 4.64 (2.20 – 9.80) <.001
Advanced Fibrosis 1.71 (.814 – 3.59) .157
Treatment Discontinuation 9.81 (3.08 – 31.3) <.001
Pretreatment Alcohol Intake (kg) 1.00 (.999 – 1.00) .303